Shanghai Shyndec Pharmaceutical Co Ltd Free Cash Flow Generation Index
Shanghai Shyndec Pharmaceutical Co Ltd free cash flow generation index. Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Free Cash Flow Generation Index of 0.86x as of September 2025. Free cash flow of CN¥418.93 Million represents 1% of operating cash flow (CN¥486.04 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Free cash flow generation index of Shanghai Shyndec Pharmaceutical Co Ltd from 2004 to 2025. Historical FCF Generation Index trend for Shanghai Shyndec Pharmaceutical Co Ltd across 22 annual periods. See 600420 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Shanghai Shyndec Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (2004–2025)
Shanghai Shyndec Pharmaceutical Co Ltd free cash flow generation index by year from 2004 to 2025. Year-by-year Free Cash Flow Generation Index for Shanghai Shyndec Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Shanghai Shyndec Pharmaceutical Co Ltd cash flow conversion.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.84x | CN¥1.43 Billion | CN¥1.70 Billion | CN¥263.83 Million | ▼ -6.4% |
| 2024 | 0.90x | CN¥2.04 Billion | CN¥2.26 Billion | CN¥219.77 Million | ▲ +13.9% |
| 2023 | 0.79x | CN¥1.36 Billion | CN¥1.72 Billion | CN¥357.19 Million | ▼ -11.2% |
| 2022 | 0.89x | CN¥2.55 Billion | CN¥2.86 Billion | CN¥307.44 Million | ▲ +29.4% |
| 2021 | 0.69x | CN¥1.16 Billion | CN¥1.68 Billion | CN¥521.44 Million | ▼ -9.0% |
| 2020 | 0.76x | CN¥1.18 Billion | CN¥1.56 Billion | CN¥377.98 Million | ▲ +11.1% |
| 2019 | 0.68x | CN¥866.32 Million | CN¥1.27 Billion | CN¥403.82 Million | ▼ -10.3% |
| 2018 | 0.76x | CN¥1.27 Billion | CN¥1.67 Billion | CN¥399.40 Million | ▼ -18.0% |
| 2017 | 0.93x | CN¥2.15 Billion | CN¥2.31 Billion | CN¥168.44 Million | ▲ +30.2% |
| 2016 | 0.71x | CN¥597.27 Million | CN¥838.58 Million | CN¥241.30 Million | ▲ +2150.6% |
| 2015 | -0.03x | CN¥-7.87 Million | CN¥226.65 Million | CN¥234.52 Million | ▲ +94.8% |
| 2014 | -0.67x | CN¥-172.02 Million | CN¥258.51 Million | CN¥430.53 Million | ▲ +54.8% |
| 2013 | -1.47x | CN¥-305.13 Million | CN¥207.50 Million | CN¥512.62 Million | ▼ -34.1% |
| 2012 | -1.10x | CN¥-212.11 Million | CN¥193.41 Million | CN¥405.52 Million | ▼ -2033.3% |
| 2011 | 0.06x | CN¥7.72 Million | CN¥136.12 Million | CN¥128.40 Million | ▲ +116.0% |
| 2010 | -0.36x | CN¥-40.91 Million | CN¥115.11 Million | CN¥156.02 Million | ▼ -152.4% |
| 2009 | 0.68x | CN¥66.14 Million | CN¥97.43 Million | CN¥31.29 Million | ▼ -11.4% |
| 2008 | 0.77x | CN¥44.49 Million | CN¥58.04 Million | CN¥13.56 Million | ▲ +31.8% |
| 2007 | 0.58x | CN¥47.86 Million | CN¥82.31 Million | CN¥34.45 Million | ▲ +268.9% |
| 2006 | 0.16x | CN¥11.60 Million | CN¥73.60 Million | CN¥62.00 Million | ▲ +166.4% |
| 2005 | -0.24x | CN¥-13.75 Million | CN¥57.90 Million | CN¥71.65 Million | ▼ -429.2% |
| 2004 | 0.07x | CN¥1.23 Million | CN¥17.02 Million | CN¥15.79 Million | — |